Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.


Autoria(s): Conen A.; Weisser M.; Jörg C.O.; Battegay M.; Trampuz A.; Frei R.; Christen S.; Heim D.; Gratwohl A.; Flückiger U.
Data(s)

2008

Resumo

Candida krusei infections are serious complications in neutropenic patients with hematological malignancies. We report the successful treatment of C. krusei infection with caspofungin in 3 allogeneic hematopoietic stem cell transplant recipients and 1 patient with induction chemotherapy for acute myeloid leukemia.

Identificador

http://serval.unil.ch/?id=serval:BIB_3FA68B3904D0

isbn:1398-2273 (Print)

pmid:17511816

doi:10.1111/j.1399-3062.2007.00238.x

isiid:000252776400013

Idioma(s)

en

Fonte

Transplant Infectious Disease, vol. 10, no. 1, pp. 66-70

Palavras-Chave #Adult; Antifungal Agents/therapeutic use; Candida/classification; Candida/drug effects; Candidiasis/drug therapy; Candidiasis/microbiology; Echinocandins/therapeutic use; Female; Hematologic Neoplasms/complications; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Middle Aged; Neutropenia/complications; Transplantation, Homologous/adverse effects; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article